ArriVent BioPharma, Inc. Common Stock
AVBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80 | -$69 | -$37 | -$52 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $1 | $0 | $0 |
| Change in WC | $7 | $13 | -$7 | -$4 |
| Other Non-Cash | $0 | $0 | $0 | $43 |
| Operating Cash Flow | -$70 | -$56 | -$44 | -$13 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$194 | -$25 | $0 | $0 |
| Inv. Sales/Matur. | $2 | $25 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$40 |
| Investing Cash Flow | -$192 | $0 | $0 | -$40 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $186 | $0 | $0 | $90 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $43 | $170 | $0 |
| Financing Cash Flow | $187 | $43 | $170 | $90 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$76 | -$13 | $126 | $37 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $150 | $163 | $37 | $0 |
| End Cash | $74 | $150 | $163 | $37 |
| Free Cash Flow | -$70 | -$56 | -$44 | -$13 |